Regulation of actin organisation by TGF-β in H-ras-transformed fibroblasts

Journal of Cell Science

Volumn 112, Issue 8, 1999, Pages 1169-1179

  Moustakas, Aristidis ^a,b   Stournaras, Christos ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

Actin; Cytoskeleton; Ras; Rho; TGF

Indexed keywords

ACTIN; ENZYME INHIBITOR; F ACTIN; G ACTIN; GUANOSINE TRIPHOSPHATASE; RHO FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; CELL TRANSFORMATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; FIBROBLAST; GENE EXPRESSION; IMMUNOBLOTTING; MOUSE; NONHUMAN; ONCOGENE H RAS; PHENOTYPE; POLYMERIZATION; PRIORITY JOURNAL;

3T3 CELLS; ACTINS; ANIMALS; BLOTTING, WESTERN; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYTOSKELETON; DEXAMETHASONE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GTP PHOSPHOHYDROLASES; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICROSCOPY, CONFOCAL; RAS PROTEINS; RATS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

ANIMALIA;

EID: 0032945213     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Actories, K., Braun, U., Rosener, S., Just, I. and Hall, A. (1989). The rho gene product expressed in E. coli is a substrate of botulinum ADP-ribosyltransferase C3. Biochem. Biophys. Res. Commun. 158, 209-213
2. Adamson, P., Paterson, H. F. and Hall, A. (1992). Intracellular localization of the P21rho proteins. J. Cell Biol. 119, 617-627.
3. Assoian, R. K. and Zhu, X. (1997). Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr. Opin. Cell Biol. 9, 93-98.
4. Ben-Ze'ev, A. (1997). Cytoskeletal and adhesion proteins as tumor suppressors. Curr. Opin. Cell Biol. 9, 99-108.
5. Chrzanowska-Wodnicka, M. and Burridge, K. (1996). Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J. Cell Biol. 133, 1403-1415.
6. Coomber, B. L. (1991). Cytoskeleton in TFG-β-and bFGF-modulated endothelial monolayer repair. Exp. Cell Res. 194, 42-47.
7. Cox, A. D. and Der, C. J. (1994). Biological assays for cellular transformation. Meth. Enzymol. 238, 277-294.
8. Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A. and Akhurst, R. J. (1996). TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86, 531-542.
9. Dartsch, P. C., Ritter, M., Häussinger, D. and Lang, F. (1994). Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene. Eur. J. Cell Biol. 63, 316-325.
10. DeCoteau, J. F., Knaus, P. I., Yankelev, H., Reis, M. D., Lowsky, R., Lodish, H. F. and Kadin, M. E. (1997). Loss of functional cell surface transforming growth factor beta (TCP-beta) type 1 receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia. Proc. Nat. Acad Sci. USA 94, 5877-5881.
11. Engel, M. E., Datta, P. K. and Moses, H. L. (1998). RhoB is stabilized by transforming growth factor β and antagonizes transcriptional activation. J. Biol. Chem. 273, 9921-9926.
12. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, K., Tsui, L.-C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L. and Attisano, L. (1996). MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86, 543-552.
13. Gutkind, J. S and Vitale-Cross, L. (1996). The pathway linking small GTP-binding proteins of the Rho family to cytoskeletal components and novel signaling kinase cascades. Cell Dev. Biol. 7, 683-690.
14. Hall, A. (1998). Rho GTPases and the actin cytoskeleton. Science 279, 509-514.
15. Heldin, C.-H., Miyazono, K. and ten Dijke, P. (1997). TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
16. 1 to S phase in growth-stimulated rat FRTL-5 cells. J. Biol. Chem. 272, 13-16.
17. Jaggi, R., Salmons, B., Muellener, D. and Groner, B. (1986). The v-mos and H-ras oncogene expression represses glucocorticoid-dependent transcription from the mouse mammary tumor virus LTR. EMBO J. 5, 2609-2616.
18. Koukouritaki, S. B., Theodoropoulos, P. A., Margioris, A. N., Gravanis, A. and Stournaras, C. (1996). Dexamethasone alters rapidly actin polymerization dynamics in human endometrial cells: evidence for nongenomic actions involving cAMP turnover. J. Cell Biochem. 62, 251-261.
19. Koukouritaki, S. B., Margioris, A. N., Gravanis, A., Hartig, R. and Stournaras, C. (1997). Dexamethasone induces rapid actin assembly in human endometrial cells without affecting its synthesis. J. Cell. Biochem. 65, 492-500.
20. Land, H., Parada, L. F. and Weinberg, R. A. (1983). Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596-602.
21. Land, H., Chen A. C., Morgenstern, J. P., Parada, L. F. and Weinberg, R. A. (1986). Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol. Cell. Biol. 6, 1917-1925.
22. Leof, E. B., Proper, J. A., Getz, M. J. and Moses, H. L. (1986). Transforming growth factor type β regulation of actin mRNA. J. Cell Physiol. 127, 83-88.
23. Lerner, E. C., Qian, Y., Hamilton, A. D. and Sebti, S. M. (1995) Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitor. J. Biol. Chem. 270, 26770-26773.
24. Lim., L., Hall, C. and Monfries, C. (1996). Regulation of actin cytoskeleton by Rho-family GTPases and their associated proteins. Cell Dev. Biol. 7, 699-706.
25. Machesky, L. M. and Hall, A. (1997). Role of actin polymerization and adhesion to extracellular matrix in Rac-and Rho-induced cytoskeletal reorganization. J. Cell Biol. 138, 913-926.
26. Mackay, D. J., Esch, F., Furthmayr, H. and Hall, A. (1997) Rho-and rac dependent assembly of focal adhesion complexes and actin filaments in permeabilized fibroblasts: an essential role for ezrin/radixin/moesin proteins. J. Cell Biol. 138, 927-938.
27. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, S., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M. and Willson, J. K. V. (1995). Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338.
28. Massagué, J. (1990). The transforming growth factor-β family. Annu. Rev. Cell. Biol. 6, 597-641.
29. Massagué, J. and Weis-Garcia, F. (1996). Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. Cancer Surv. 27, 41-64.
30. Moustakas, A., Lin, H. Y., Henis, Y. I., Plamondon, J., O'Connor-McCourt, M. D. and Lodish, H. F. (1993). The transforming growth factor β receptors types I, II and III form hetero-oligomeric complexes in the presence of ligand. J. Biol. Chem. 268, 22215-22218.
31. Oft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H. and Reichmann, E. (1996). TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10, 2462-2477.
32. +/Pi co-transport alters rapidly cytoskeletal protein polymerization dynamics in opossum kidney cells. Biochem J. 315. 241-247.
33. Papakonstanti, E. A., Bakogeorgou, E., Castanas, E., Emmanouel, D. S., Hartig, R. and Stournaras, C. (1998). Early alterations of actin cytoskeleton in OK cells by opioids. J. Cell. Biochem. 70, 60-69.
34. rho induces rapid changes in cell morphology. J. Cell Biol. 111, 1001-1007.
35. Qiu, R. G., Chen, J., McCormick, F. and Symons, M. (1995). A role for Rho in Ras transformation. Proc: Nat. Acad. Sci. USA 92, 11781-11785.
36. Riggins, G. J., Kinzler, K. W., Vogelstein, B. and Thiagalingam, S. (1997). Frequency of Smad gene mutations in human cancers. Cancer Res. 57, 2578-2580.
37. Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S., Stern, D. F. and Sporn, M. B. (1985). Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc. Nat. Acad. Sci. USA 82, 119-123.
38. Roberts, A. B. and Sporn, M. B. (1990). The transforming growth factor-βs. In Peptide Growth Factors and Their Receptors: Handbook of Experimental Pharmacology, vol. 95 (ed. M. B. Sporn and A. B. Roberts), pp. 421-472. Springer-Verlag, Heidelberg, Germany.
39. Rodriguez-Viciana, P., Warne, P. H., Khwaja, A., Marte, B. M., Pappin, D., Das, P., Waterfield, M. D., Ridley, A. and Downward, J. (1997). Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89, 457-467.
40. Segarini, P. R., Rosen, D. M. and Seyedin, S. M. (1989). Binding of transforming growth factor-β to cell surface proteins varies with cell type. Mol. Endocrinol. 3, 261-272.
41. Stournaras, C., Stiakaki, E., Koukouritaki, S. B., Theodoropoulos, P. A., Kalmanti, M., Fostinis, Y. and Gravanis, A. (1996). Altered actin polymerization dynamics in various malignant cell types: evidence for differential sensitivity to cytochalasin B. Biochem. Pharmacol. 52, 1339-1346.
42. Tapon, N. and Hall, A. (1997). Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr. Opin. Cell Biol. 9, 86-92.
43. ten Dijke, P., Miyazono, K. and Heldin, C.-H. (1996). Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr. Opin. Cell Biol. 8, 139-145.
44. Wang, J., Han, W., Zborowska, E., Liang, J., Wang, X., Willson, J. K. V., Sun, L. and Brattain, M. G. (1996). Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells. J. Biol. Chem. 271, 17366-17371.
45. 1 phase of the cell cycle. Oncogene 8, 1449-1455.
46. Zhong, C., Kinch, M. S. and Burridge, K. (1997). Rho-stimulated contractility contributes to the fibroblastic phenotype of Ras-transformed epithelial cells. Mol. Biol. Cell 8, 2329-2344.